The tissue organization field theory of cancer: A testable replacement for the somatic mutation theory

BioEssays

Volumn 33, Issue 5, 2011, Pages 332-340

  Soto, Ana M ^a   Sonnenschein, Carlos ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer theories; Carcinogenesis; Mutations; Proliferation

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; HUMAN; MORPHOGENESIS; MUTAGENESIS; NEOPLASM; NEPHRON; NUCLEOTIDE SEQUENCE; RETROPOSON; SOMATIC MUTATION; TISSUE; TISSUE CHARACTERIZATION; TISSUE ORGANIZATION FIELD THEORY; TUMOR CELL;

MODELS, BIOLOGICAL; MUTATION; NEOPLASMS;

EID: 79954623572     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201100025     Document Type: Article

References (78)

1. Boveri T. 1929. The Origin of Malignant Tumors. Baltimore, MD: Williams & Wilkins. pp. 62-63.
2. Avery OT, MacLeod CM, McCarty M. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. J Exp Med 79: 137-58.
3. Watson JD, Crick FHC. 1953. Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid. Nature 171: 737-8.
4. Wilkins MHF, Stokes AR, Wilson HR. 1953. Molecular structure of deoxypentose nucleic acids. Nature 171: 738-40.
5. Franklin R, Gosling RG. 1953. Molecular configuration in sodium thymonucleate. Nature 171: 740-1.
6. Gottlieb B, Beitel LK, Trifiro M. 2007. Will knowledge of human genome variation result in changing cancer paradigms? BioEssays 29: 678-85.
7. Schreiber TH, Podack ER. 2009. A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas. Br J Cancer 101: 381-6.
8. Triolo VA. 1965. Nineteenth century foundations of cancer research advances in tumor pathology, nomenclature, and theories of oncogenesis. Cancer Res 25: 76-98.
9. Brash D, Cairns J. 2009. The mysterious steps in carcinogenesis. Br J Cancer 101: 379-80.
10. Sonnenschein C, Soto AM. 1999. The Society of Cells: Cancer and Control of Cell Proliferation. New York, NY: Springer Verlag. pp. 99-133.
11. Smithers DW. 1962. Cancer: an attack of cytologism. Lancet 1: 493-9.
12. Tlsty T. 2008. Cancer: whispering sweet somethings. Nature 453: 604-5.
13. Wicha MS, Liu S, Dontu G. 2006. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66: 1883-90.
14. Petersen OW, Polyak K. 2010. Stem cells in the human breast. Cold Spring Harb Perspect Biol 2: a003160.
15. Kreeger PK, Lauffenburger DA. 2010. Cancer systems biology: a network modeling perspective. Carcinogenesis 31: 2-8.
16. Dennett DC. 1995. Darwin's Dangerous Idea. New York, NY: Simon & Schuster.
17. Serluca FC, Drummond IA, Fishman MC. 2002. Endothelial signaling in kidney morphogenesis: a role for hemodynamic forces. Curr Biol 12: 492-7.
18. Vasilyev A, Liu Y, Mudumana S, Mangos S, et al. 2009. Collective cell migration drives morphogenesis of the kidney nephron. PLoS Biol 7: e9.
19. Mammoto T, Ingber DE. 2010. Mechanical control of tissue and organ development. Development 137: 1407-20.
20. Soto AM, Sonnenschein C, Miquel P-A. 2008. On physicalism and downward causation in developmental and cancer biology. Acta Biotheor 56: 257-74.
21. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57-70.
22. Weinberg RA. 2006. The Biology of Cancer. New York, NY: Taylor & Francis.
23. Krontiris TG, Cooper GM. 1981. Transforming activity of human tumor DNAs. Proc Natl Acad Sci USA 78: 1181-4.
24. Shih C, Padhy LC, Murray M, Weinberg RA. 1981. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261-4.
25. Reddy EP, Reynolds RK, Santos E, Barbacid M. 1982. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300: 149-52.
26. Barbacid M, Ortega S, Sotillo R, Odajima J, et al. 2005. Cell cycle and cancer: genetic analysis of the role of cyclin-dependent kinases. Cold Spring Harb Symp Quant Biol 70: 233-40.
27. Rubin H. 2006. What keeps cells in tissues behaving normally in the face of myriad mutations? BioEssays 28: 515-24.
28. Harris H. 2005. A long view of fashions in cancer research. BioEssays 27: 833-8.
29. Alberts B, Bray D, Lewis JG, Raff M, et al. 1994. Molecular Biology of the Cell. New York, NY: Garland Publishing Inc. p. 891.
30. Varmus HE, Weinberg RA. 1992. Genes and the Biology of Cancer. New York, NY: Scientific American Library. p. 123.
31. Sonnenschein C, Soto AM. 1999. The Society of Cells: Cancer and Control of Cell Proliferation. New York, NY: Springer Verlag.
32. Soto AM, Sonnenschein C. 2004. The somatic mutation theory of cancer: growing problems with the paradigm? BioEssays 26: 1097-107.
33. Bizzarri M, Cucina A, Conti F, D'Anselmi F. 2008. Beyond the oncogene paradigm: understanding complexity in cancerogenesis. Acta Biotheor 56: 173-96.
34. Sonnenschein C, Soto AM. 2008. Theories of carcinogenesis: an emerging perspective. Semin Cancer Biol 18: 372-7.
35. Alberts B, Bray D, Lewis JG, Raff M, et al. 1994. Molecular Biology of the Cell. New York, NY: Garland Publishing Inc. pp. 1255-1294.
36. Moody CA, Laimins LA. 2010. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10: 550-60.
37. Cowin PA, Anglesio M, Etemadmoghadam D, Bowtell DD. 2010. Profiling the cancer genome. Annu Rev Genomics Hum Genet 11: 133-59.
38. Strausberg RL, Simpson AJ. 2010. Whole-genome cancer analysis as an approach to deeper understanding of tumour biology. Br J Cancer 102: 243-8.
39. Alberts B, Johnson A, Lewis J, Raff M, et al. 2008. Molecular Biology of the Cell. New York, NY: Garland Science.
40. Stratton MR, Campbell PJ, Futreal PA. 2009. The cancer genome. Nature 458: 719-24.
41. Sharma S, Kelly TK, Jones PA. 2010. Epigenetics in cancer. Carcinogenesis 31: 27-36.
42. Wilkins AS. 2010. The enemy within: an epigenetic role of retrotransposons in cancer initiation. BioEssays 32: 856-65.
43. Patocs A, Zhang L, Xu Y, Weber F, et al. 2009. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 357: 2543-51.
44. Qiu W, Hu M, Sridhar A, Opeskin K, et al. 2008. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 40: 650-5.
45. Hosein AN, Wu M, Arcand SL, Lavallee S, et al. 2010. Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations. Cancer Res 70: 5770-7.
46. Duda DG, Duyverman AM, Kohno M, Snuderl M, et al. 2010. Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci USA 107: 21677-82.
47. Greenman C, Stephens P, Smith R, Dalgliesh GL, et al. 2007. Patterns of somatic mutation in human cancer genomes. Nature 446: 153-8.
48. Wood LD, Parsons DW, Jones S, Lin J, et al. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-13.
49. Yachida S, Jones S, Bozic I, Antal T, et al. 2010. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-7.
50. Akavia UD, Litvin O, Kim J, Sanchez-Garcia F, et al. 2010. An integrated approach to uncover drivers of cancer. Cell 143: 1005-17.
51. Martin GM, Ogburn CE, Colgin LM, Gown AM, et al. 1996. Somatic mutations are frequent and increase with age in human kidney epithelial cells. Hum Mol Genet 5: 215-21.
52. Rehen SK, McConnell MJ, Kaushal D, Kingsbury MA, et al. 2001. Chromosomal variation in neurons of the developing and adult mammalian nervous system. Proc Natl Acad Sci USA 98: 13361-6.
53. Cooper M. 2009. Regenerative pathologies: stem cells, teratomas, and theories of cancer. Med Stud 1: 55-66.
54. Virchow R. 1860. Cellular Pathology. John Churchill. pp. 441-443.
55. Mintz B, Ilmensee K. 1975. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 72: 3585-9.
56. McCullough AR, Coleman WB, Smith GJ, Grisham JW. 1997. Age-dependent induction of hepatic tumor regression by the tissue microenvironment after transplantation of noplastically transformed rat liver epithelial cells into the liver. Cancer Res 57: 1807-73.
57. Kasemeier-Kulesa JC, Teddy JM, Postovit LM, Seftor EA, et al. 2008. Reprogramming multipotent tumor cells with the embryonic neural crest microenvironment. Dev Dyn 237: 2657-66.
58. Maffini MV, Calabro JM, Soto AM, Sonnenschein C. 2005. Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma. Am J Pathol 67: 1405-10.
59. Orr JW, Spencer AT. 1972. Transplantation studies of the role of the stroma in epidermal carcinogenesis. In Tarin D, eds; Tissue Interactions in Carcinogenesis. London, UK: Academic Press. pp. 291-304.
60. Barcellos-Hoff MH, Ravani SA. 2000. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 60: 1254-60.
61. Maffini MV, Soto AM, Calabro JM, Ucci AA, et al. 2004. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 117: 1495-502.
62. Barclay WW, Woodruff RD, Hall MC, Cramer SD. 2005. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology 146: 13-8.
63. Prehn RT. 1994. Cancers beget mutations versus mutations beget cancers. Cancer Res 54: 5296-300.
64. Illmensee K, Mintz B. 1976. Totipotency and normal differentiation of single teratocarcinoma cell cloned by injection into blastocysts. Proc Natl Acad Sci USA 73: 549-53.
65. Coleman W, Wennerberg AE, Smith GJ, Grisham JW. 1997. Regulation of the differentiation of diploid and aneuploid rat liver epithelial (stem-like) cells by the liver microenvironment. Am J Pathol 142: 1373-82.
66. Lakatos I., 1970. Falsification and the methodology of scientific research programmes. In Lakatos I, Musgrave A, eds; Criticism and the Growth of Knowledge. Cambridge, UK: Cambridge University Press.
67. Marcum JA. 2005. Metaphysical presuppositions and scientific practices: reductionism and organicism in cancer research. Int Stud Philos Sci 19: 31-45.
68. Aranda-Anzaldo A. 2001. Cancer development and progression: a non-adaptive process driven by genetic drift. Acta Biotheor 49: 89-108.
69. Kuhn TS. 1962. The Structure of Scientific Revolutions. Chicago, IL: University of Chicago Press.
70. Baker SG, Soto AM, Sonnenschein C, Cappuccio A, et al. 2009. Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats. BMC Cancer 9: 89-99.
71. Brodeur GM. 2003. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-16.
72. Haas D, Ablin AR, Miller C, Zoger S, et al. 1988. Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer 62: 818-25.
73. Huggins C. 1967. Endocrine-induced regression of cancers. Science 156: 1050-4.
74. Jordan VC, Lewis-Wambi JS, Patel RR, Kim H, et al. 2009. New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis. Breast 3: S10-7.
75. Debruyne F. 2002. Hormonal therapy of prostate cancer. Semin Urol Oncol 3: 4-9.
76. Bussard KM, Boulanger CA, Booth BW, Bruno RD, et al. 2010. Reprogramming human cancer cells in the mouse mammary gland. Cancer Res 70: 6336-43.
77. Bischoff F, Bryson G. 1964. Carcinogenesis through solid state surfaces. Prog Exp Tumor Exp Tumor Res 5: 85-133.
78. Stevens LC. 1970. The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev Biol 21: 364-82.